180 related articles for article (PubMed ID: 37321669)
1. Intravenous versus subcutaneous tocilizumab in Takayasu arteritis: multicentre retrospective study.
Mekinian A; Biard L; Lorenzo D; Novikov PI; Salvarani C; Espitia O; Sciascia S; Michaud M; Lambert M; Hernández-Rodríguez J; Schleinitz N; Awisat A; Puechal X; Aouba A; Munoz Pons H; Smitienko I; Gaultier JB; Edwige LM; Benhamou Y; Perlat A; Jego P; Goulenok T; Sacre K; Lioger B; Hassold N; Broner J; Dufrost V; Sené T; Seguier J; Maurier F; Berthier S; Belot A; Frikha F; Denis G; Audemard-Verger A; Koné-Paut I; Humbert S; Woaye-Hune P; Tomelleri A; Baldissera EM; Kuwana M; Lo Gullo A; Mukuchyan V; Dellal A; Gaches F; Zeminsky P; Galli E; Alvarado M; Boiardi L; Muratore F; Vautier M; Campochiaro C; Moiseev S; Vieira M; Cacoub P; Fain O; Saadoun D;
RMD Open; 2023 Jun; 9(2):. PubMed ID: 37321669
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of TNF-α antagonists and tocilizumab in Takayasu arteritis: multicentre retrospective study of 209 patients.
Mekinian A; Biard L; Dagna L; Novikov P; Salvarani C; Espitia O; Sciascia S; Michaud M; Lambert M; Hernández-Rodríguez J; Schleinitz N; Awisat A; Puéchal X; Aouba A; Munoz Pons H; Smitienko I; Gaultier JB; Le Mouel E; Benhamou Y; Perlat A; Jego P; Goulenok T; Sacre K; Lioger B; Hassold N; Broner J; Dufrost V; Sene T; Seguier J; Maurier F; Berthier S; Belot A; Frikha F; Denis G; Audemard-Verger A; Kone Pault I; Humbert S; Woaye-Hune P; Tomelleri A; Baldissera E; Kuwana M; Lo Gullo A; Gaches F; Zeminsky P; Galli E; Alvarado M; Boiardi L; Muratore F; Vautier M; Campochiaro C; Moiseev S; Cacoub P; Fain O; Saadoun D;
Rheumatology (Oxford); 2022 Apr; 61(4):1376-1384. PubMed ID: 34363461
[TBL] [Abstract][Full Text] [Related]
3. A multicentre, large-scale, observational study of tocilizumab in patients with Takayasu arteritis in Japan: The ACTEMRA® (ACT)-Bridge study.
Harigai M; Miyamae T; Hashimoto H; Yoshida A; Yamashita K; Nakaoka Y
Mod Rheumatol; 2023 Aug; 33(5):998-1006. PubMed ID: 36057089
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of Biological-Targeted Treatments in Takayasu Arteritis: Multicenter, Retrospective Study of 49 Patients.
Mekinian A; Comarmond C; Resche-Rigon M; Mirault T; Kahn JE; Lambert M; Sibilia J; Néel A; Cohen P; Hie M; Berthier S; Marie I; Lavigne C; Anne Vandenhende M; Muller G; Amoura Z; Devilliers H; Abad S; Hamidou M; Guillevin L; Dhote R; Godeau B; Messas E; Cacoub P; Fain O; Saadoun D;
Circulation; 2015 Nov; 132(18):1693-700. PubMed ID: 26354797
[TBL] [Abstract][Full Text] [Related]
5. The effectiveness of tocilizumab and its comparison with tumor necrosis factor alpha inhibitors for Takayasu Arteritis: A systematic review and meta-analysis.
Misra DP; Singh K; Rathore U; Patro P; Tomelleri A; Campochiaro C; Agarwal V; Sharma A
Autoimmun Rev; 2023 Mar; 22(3):103275. PubMed ID: 36652977
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of tocilizumab in patients with refractory Takayasu arteritis: results from a randomised, double-blind, placebo-controlled, phase 3 trial in Japan (the TAKT study).
Nakaoka Y; Isobe M; Takei S; Tanaka Y; Ishii T; Yokota S; Nomura A; Yoshida S; Nishimoto N
Ann Rheum Dis; 2018 Mar; 77(3):348-354. PubMed ID: 29191819
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of tocilizumab in Takayasu arteritis: Multicenter retrospective study of 46 patients.
Mekinian A; Resche-Rigon M; Comarmond C; Soriano A; Constans J; Alric L; Jego P; Busato F; Cabon M; Dhote R; Estibaliz L; Koné-Paut I; Landron C; Lavigne C; Lioger B; Michaud M; Ruivard M; Sacre K; Gottenberg JE; Gaches F; Goulenok T; Salvarani C; Cacoub P; Fain O; Saadoun D;
J Autoimmun; 2018 Jul; 91():55-60. PubMed ID: 29678346
[TBL] [Abstract][Full Text] [Related]
8. Tocilizumab in treatment-naïve patients with Takayasu arteritis: TOCITAKA French prospective multicenter open-labeled trial.
Mekinian A; Saadoun D; Vicaut E; Thietart S; Lioger B; Jego P; Bleibtreu A; Limal N; Connault J; Gottenberg JE; Lhorte P; Bertola JP; Delforge J; Ferreira-Maldent N; Perlat A; Talib Z; Vautier M; Savey L; Quiere I; Cacoub P; Fain O;
Arthritis Res Ther; 2020 Sep; 22(1):218. PubMed ID: 32943098
[TBL] [Abstract][Full Text] [Related]
9. Tocilizumab treatment effectively improves coronary artery involvement in patients with Takayasu arteritis.
Pan L; Du J; Liu J; Liao H; Liu X; Guo X; Liang J; Han H; Yang L; Zhou Y
Clin Rheumatol; 2020 Aug; 39(8):2369-2378. PubMed ID: 32144625
[TBL] [Abstract][Full Text] [Related]
10. Long-term efficacy and safety of tocilizumab in refractory Takayasu arteritis: final results of the randomized controlled phase 3 TAKT study.
Nakaoka Y; Isobe M; Tanaka Y; Ishii T; Ooka S; Niiro H; Tamura N; Banno S; Yoshifuji H; Sakata Y; Kawakami A; Atsumi T; Furuta S; Kohsaka H; Suzuki K; Hara R; Maejima Y; Tsukamoto H; Takasaki Y; Yamashita K; Okada N; Yamakido S; Takei S; Yokota S; Nishimoto N
Rheumatology (Oxford); 2020 Sep; 59(9):2427-2434. PubMed ID: 31951279
[TBL] [Abstract][Full Text] [Related]
11. Intravenous tocilizumab for Takayasu arteritis with aortic aneurysms, bilateral renal artery stenosis, and atypical aortic coarctation in a 2-year-old girl.
Fujita Y; Tomiita M; Saida S; Omura S; Sato M; Otsubo Y; Takagi Y; Kano Y; Sekine K; Fukushima K; Kuwashima S; Yoshihara S
Mod Rheumatol Case Rep; 2023 Jan; 7(1):160-165. PubMed ID: 36018053
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of tocilizumab for refractory Takayasu arteritis: a retrospective study and literature review.
Li H; Shuai Z
Heart Vessels; 2022 May; 37(5):884-894. PubMed ID: 34750666
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of tocilizumab in treatment of Takayasu arteritis: A systematic review of randomized controlled trials.
Singh A; Danda D; Hussain S; Najmi AK; Mathew A; Goel R; Lakhan SE; Tajudheen B; Antony B
Mod Rheumatol; 2021 Jan; 31(1):197-204. PubMed ID: 32000551
[TBL] [Abstract][Full Text] [Related]
14. Development of severe colitis in Takayasu arteritis treated with tocilizumab.
Ishii K; Shirai T; Kakuta Y; Machiyama T; Sato H; Ishii T; Harigae H; Fujii H
Clin Rheumatol; 2022 Jun; 41(6):1911-1918. PubMed ID: 35188603
[TBL] [Abstract][Full Text] [Related]
15. Takayasu arteritis and large-vessel giant cell arteritis in Italian population. Comprehensive analysis from a single institutional cohort of 184 cases.
Boiardi L; Galli E; Macchioni P; Muratore F; Klinowski G; Hunder GG; Casali M; Besutti G; Spaggiari L; Versari A; Croci S; Mancuso P; Rossi PG; Marvisi C; Salvarani C
Semin Arthritis Rheum; 2023 Apr; 59():152173. PubMed ID: 36780709
[TBL] [Abstract][Full Text] [Related]
16. Infantile Takayasu: clinical features and long-term outcome.
Miller-Barmak A; Sztajnbok F; Balik Z; Borzutzky A; Fogel LA; Goldzweig O; Ozen S; Butbul Aviel Y
Rheumatology (Oxford); 2023 Sep; 62(9):3126-3132. PubMed ID: 36495199
[TBL] [Abstract][Full Text] [Related]
17. Presentation and clinical course of pediatric-onset versus adult-onset Takayasu arteritis-a systematic review and meta-analysis.
Misra DP; Rathore U; Kopp CR; Patro P; Agarwal V; Sharma A
Clin Rheumatol; 2022 Dec; 41(12):3601-3613. PubMed ID: 35927524
[TBL] [Abstract][Full Text] [Related]
18. Tocilizumab monotherapy for large vessel vasculitis: results of 104-week treatment of a prospective, single-centre, open study.
Saito S; Okuyama A; Okada Y; Shibata A; Sakai R; Kurasawa T; Kondo T; Takei H; Amano K
Rheumatology (Oxford); 2020 Jul; 59(7):1617-1621. PubMed ID: 31665468
[TBL] [Abstract][Full Text] [Related]
19. Vascular imaging of patients with refractory Takayasu arteritis treated with tocilizumab: post hoc analysis of a randomized controlled trial.
Nakaoka Y; Yanagawa M; Hata A; Yamashita K; Okada N; Yamakido S; Hayashi H; Jayne D
Rheumatology (Oxford); 2022 May; 61(6):2360-2368. PubMed ID: 34528074
[TBL] [Abstract][Full Text] [Related]
20. Systematic review and meta-analysis of the current literature on tocilizumab in patients with refractory Takayasu arteritis.
Kang L; Liu Y; Luo Z; Zhou Y; Chen B; Yin G; Xie Q
Front Immunol; 2023; 14():1084558. PubMed ID: 36845158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
